MX9806252A - Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios. - Google Patents
Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios.Info
- Publication number
- MX9806252A MX9806252A MX9806252A MX9806252A MX9806252A MX 9806252 A MX9806252 A MX 9806252A MX 9806252 A MX9806252 A MX 9806252A MX 9806252 A MX9806252 A MX 9806252A MX 9806252 A MX9806252 A MX 9806252A
- Authority
- MX
- Mexico
- Prior art keywords
- atoms
- branched
- straight
- cyclic alkyl
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
Un compuesto que tiene la estructura (I) en la cual (a) n es de aproximadamente 1 a aproximadamente 3; (b) X es seleccionada del grupo que consiste en 0, S, So, SO2, (c) y es independientemente hidrogeno o alquilo de cadena recta, ramificado o cíclico que tiene de alrededor de 1 a alrededor de 4 átomos de carbono, o las Y están enlazadas para formar un anillo alcanilo que tiene de aproximadamente 3 a aproximadamente 7 átomos; (d) Z es hidrogeno o alquilo de cadena recta, ramificada o cíclica que tiene de 3 a aproximadamente 10 átomos distintos al hidrogeno; (e) W es hidrogeno o alquilo de cadena recta, ramificada o cíclica, arilo, hidroxi o alcoxi; y (f) R1 y R2 son independientemente hidrogeno o alquilo de cadena recta, ramificada o cíclica que tienen de 1 a 10 carbonos, arilo, heterocíclico, heteroarilo, hidroxi o alcoxi; o R1 y R2 están enlazados para formar un anillo que tiene de 3 a aproximadamente 7 átomos en los cuales 1 a 3 átomos pueden ser heteroátomos; composiciones farmacéuticas que consisten en dichos compuestos, y métodos para el tratamiento de inflamacion o dolor utilizando dichos compuestos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/595,086 US5672620A (en) | 1996-02-01 | 1996-02-01 | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9806252A true MX9806252A (es) | 1998-11-30 |
Family
ID=24381674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9806252A MX9806252A (es) | 1996-02-01 | 1998-08-03 | Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5672620A (es) |
EP (1) | EP0891346B1 (es) |
JP (1) | JP3095425B2 (es) |
KR (1) | KR100322403B1 (es) |
CN (1) | CN1120838C (es) |
AT (1) | ATE266652T1 (es) |
AU (1) | AU730310B2 (es) |
BR (1) | BR9707266A (es) |
CA (1) | CA2244196C (es) |
DE (1) | DE69729083T2 (es) |
DK (1) | DK0891346T3 (es) |
ES (1) | ES2221034T3 (es) |
MX (1) | MX9806252A (es) |
NO (1) | NO983531L (es) |
WO (1) | WO1997028148A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6319944B1 (en) * | 1999-05-10 | 2001-11-20 | Merck & Co., Inc. | Aryl amidines, compositions containing such compounds and methods of use |
DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
GB0503672D0 (en) * | 2005-02-23 | 2005-03-30 | Astrazeneca Ab | New process |
CN103259027A (zh) | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | 药物信息系统 |
KR20090071598A (ko) | 2006-09-18 | 2009-07-01 | 랩터 파마슈티컬 인코포레이티드 | 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료 |
PT2398500T (pt) | 2009-02-20 | 2019-06-14 | 2 Bbb Medicines B V | Sistema de entrega de medicamentos à base de glutationas |
TWI556839B (zh) | 2009-05-06 | 2016-11-11 | 研究室護膚股份有限公司 | 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法 |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
EP2641903B1 (de) | 2012-03-19 | 2014-10-22 | Symrise AG | Dihydrobenzofuran-Derivate als Riech- und/oder Aromastoffe |
JP6073939B2 (ja) * | 2015-01-27 | 2017-02-01 | ちえ子 前田 | 外綴組み合わせファイル |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3551456A (en) * | 1968-04-18 | 1970-12-29 | Universal Oil Prod Co | Acetyl derivatives of substituted chromans and coumarans |
JPS6031829B2 (ja) * | 1975-06-26 | 1985-07-24 | ウェルファイド株式会社 | アミノアルコ−ル誘導体の製造法 |
FR2332010A1 (fr) * | 1975-11-18 | 1977-06-17 | Continental Pharma | Amino-alcool heterocyclique, son sel et son procede de preparation |
FR2370472A2 (fr) * | 1976-11-10 | 1978-06-09 | Continental Pharma | Amino-alcool heterocyclique, son sel et son procede de preparation |
CH615031A5 (es) * | 1976-04-30 | 1979-12-28 | Gretag Ag | |
JPS6019305B2 (ja) * | 1976-07-02 | 1985-05-15 | ウェルファイド株式会社 | ジヒドロベンゾフラン誘導体 |
JPS603305B2 (ja) * | 1976-12-27 | 1985-01-26 | エーザイ株式会社 | 2,3―ジハイドロベンゾフラン誘導体 |
US4130666A (en) * | 1977-05-16 | 1978-12-19 | Riker Laboratories, Inc. | Anti-inflammatory method |
IT1093805B (it) * | 1978-01-31 | 1985-07-26 | Erba Carlo Spa | Derivati del 2h-benzofuran-3-one e procedimento per la loro preparazione |
EP0026593A1 (en) * | 1979-09-15 | 1981-04-08 | Pfizer Limited | Bicyclic keto- and amino- acids, esters and amides and pharmaceutical compositions thereof |
GR81257B (es) * | 1982-12-04 | 1984-12-11 | Lilly Industries Ltd | |
EP0117675B1 (en) * | 1983-02-19 | 1986-07-23 | Beecham Group Plc | Benzofuran and benzothiophene-carboxylic-acid derivatives |
FI842738A (fi) * | 1983-07-14 | 1985-01-15 | Syntex Inc | Aroylbenzofuran- och benzotiofenaettik- och propionsyror. |
US4613611A (en) * | 1983-10-14 | 1986-09-23 | American Cyanamid Company | Method of treating diabetes mellitus using arylglyoxals |
AU4261285A (en) * | 1984-06-01 | 1985-12-05 | Tokyo Tanabe Company Limited | 1-propanone derivatives |
US4708966A (en) * | 1986-06-27 | 1987-11-24 | The Procter & Gamble Company | Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation |
FR2613364B1 (fr) * | 1987-04-01 | 1989-06-09 | Adir | Nouvelles amines tricycliques derivees du tetrahydro-5, 6, 7, 8 naphto (2, 3b) dihydro-2, 3 furanne, et du tetrahydro-6, 7, 8, 9 5h-benzocyclohepta (2, 3b) dihydro-2, 3 furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
FR2613365B1 (fr) * | 1987-04-01 | 1989-07-28 | Adir | Nouveaux derives de l'amino tetrahydro-5, 6, 7, 8 naphto (2, 3b) furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
US4849428A (en) * | 1987-11-23 | 1989-07-18 | The Procter & Gamble Company | Cyclic anti-inflammatory derivatives of di-tert-butylphenol compounds, compositions and use |
IL88674A0 (en) * | 1987-12-18 | 1989-07-31 | Norwich Eaton Pharma | Preparation of certain substituted aromatic compounds |
US4982006A (en) * | 1987-12-18 | 1991-01-01 | Norwich Eaton Pharmaceuticals, Inc. | Process for the preparation of certain substituted aromatic compounds |
JPH07121933B2 (ja) * | 1988-03-28 | 1995-12-25 | キッセイ薬品工業株式会社 | ジヒドロベンゾフラノン誘導体 |
GB8906166D0 (en) * | 1989-03-17 | 1989-05-04 | Pfizer Ltd | Therapeutic agents |
JP2808460B2 (ja) * | 1989-11-16 | 1998-10-08 | 大正製薬株式会社 | イミダゾール誘導体 |
JPH03215485A (ja) * | 1990-01-11 | 1991-09-20 | Taisho Pharmaceut Co Ltd | ベンゾチエニルイミダゾール誘導体 |
TW197435B (es) * | 1990-11-22 | 1993-01-01 | Takeda Pharm Industry Co Ltd | |
JPH06263733A (ja) * | 1993-01-14 | 1994-09-20 | Sankyo Co Ltd | ベンゼン誘導体 |
ES2301161T3 (es) * | 1994-07-27 | 2008-06-16 | Vanderbilt University | Compuestos de dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios. |
US5684002A (en) * | 1994-09-07 | 1997-11-04 | The Procter & Gamble Company | Dihydorbenzofuran and related compounds useful as anti-inflammatory agents |
-
1996
- 1996-02-01 US US08/595,086 patent/US5672620A/en not_active Expired - Fee Related
-
1997
- 1997-01-30 DE DE69729083T patent/DE69729083T2/de not_active Expired - Fee Related
- 1997-01-30 JP JP09527763A patent/JP3095425B2/ja not_active Expired - Fee Related
- 1997-01-30 CN CN97191976A patent/CN1120838C/zh not_active Expired - Fee Related
- 1997-01-30 WO PCT/US1997/001316 patent/WO1997028148A1/en active IP Right Grant
- 1997-01-30 AT AT97904021T patent/ATE266652T1/de not_active IP Right Cessation
- 1997-01-30 DK DK97904021T patent/DK0891346T3/da active
- 1997-01-30 BR BR9707266A patent/BR9707266A/pt not_active Application Discontinuation
- 1997-01-30 KR KR1019980705952A patent/KR100322403B1/ko not_active IP Right Cessation
- 1997-01-30 CA CA002244196A patent/CA2244196C/en not_active Expired - Fee Related
- 1997-01-30 EP EP97904021A patent/EP0891346B1/en not_active Expired - Lifetime
- 1997-01-30 ES ES97904021T patent/ES2221034T3/es not_active Expired - Lifetime
- 1997-01-30 AU AU18434/97A patent/AU730310B2/en not_active Ceased
-
1998
- 1998-07-31 NO NO983531A patent/NO983531L/no not_active Application Discontinuation
- 1998-08-03 MX MX9806252A patent/MX9806252A/es not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2221034T3 (es) | 2004-12-16 |
DE69729083D1 (de) | 2004-06-17 |
JP3095425B2 (ja) | 2000-10-03 |
ATE266652T1 (de) | 2004-05-15 |
EP0891346A1 (en) | 1999-01-20 |
CA2244196C (en) | 2003-09-23 |
US5672620A (en) | 1997-09-30 |
CA2244196A1 (en) | 1997-08-07 |
CN1210528A (zh) | 1999-03-10 |
NO983531D0 (no) | 1998-07-31 |
AU1843497A (en) | 1997-08-22 |
KR100322403B1 (ko) | 2002-05-09 |
DK0891346T3 (da) | 2004-08-09 |
JPH11504347A (ja) | 1999-04-20 |
DE69729083T2 (de) | 2004-09-23 |
EP0891346B1 (en) | 2004-05-12 |
NO983531L (no) | 1998-09-28 |
CN1120838C (zh) | 2003-09-10 |
WO1997028148A1 (en) | 1997-08-07 |
BR9707266A (pt) | 1999-04-13 |
KR19990082224A (ko) | 1999-11-25 |
AU730310B2 (en) | 2001-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9806248A (es) | Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios. | |
BR9508901A (pt) | Di-hidrobenzofurano e composto relacionados utilizáveis como agentes antiflamatórios | |
MX9806251A (es) | Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios. | |
MX9806252A (es) | Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios. | |
IL127379A0 (en) | Dihydrobenzopyran and related compounds useful as anti-inflammatory agents | |
AU1843097A (en) | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents | |
MX9806253A (es) | Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios. | |
MX9806247A (es) | Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios. | |
MX9700726A (es) | Dihidrobenzofurano y compuestos relacionados, utiles como agentes antiinflamatorios. | |
CA2244245A1 (en) | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
PD | Change of proprietorship |
Owner name: VANDERBILT UNIVERSITY |
|
MM | Annulment or lapse due to non-payment of fees |